Provider records sourced from NPPES (CMS National Plan & Provider Enumeration System). Data current as of October 4, 2026.
NPIDirectory

Guil Rozenbaum Lerner, MD

Individual provider Student in an Organized Health Care Education/Training Program · NPI 1083233191

Guil Rozenbaum Lerner, MD is registered under Pulmonary Disease in Gainesville, Florida. Qualified in 2017, 9 years ago. Works from 4 locations. Licensed in Florida.

Years since qualifying
9
Licensed in
FL
In the registry since
2020
Specialties on file
3
What do these letters mean?
MD — Doctor of Medicine
A physician who completed allopathic medical school.

See every abbreviation used in this directory →

Claim this listing Report a problem Suggest an edit

Practice location Address checks out

Student / training record This NPI belongs to someone enrolled in a health care training programme. It carries no licence and no practice of its own, so no address or phone number is published for it.

Gainesville, FL

No coordinates on file. Search this address in Google Maps

Additional practice locations (3)

  • 2000 Sw Archer Rd, Gainesville, FL 32608-1136 — (352) 273-8992
  • 1600 Sw Archer Rd, Gainesville, FL 32610-3003 — (352) 273-8992
  • 1611 Nw 12th Avenue, Miami, FL 33136 — (305) 585-5215

Specialties & licences

Pulmonary Disease Physician (primary) Taxonomy 207RP1001X · Licence ME177047 (FL)
Student in an Organized Health Care Education/Training Program Taxonomy 390200000X
Critical Care Medicine (Internal Medicine) Physician Taxonomy 207RC0200X · Licence ME177047 (FL)

Record details

NPI number1083233191
Entity typeIndividual (Type 1)
GenderFemale
Credentials MD
Sole proprietorNo
NPI enumeratedApril 9, 2020
Last updated in NPPESAugust 7, 2026
Certification dateAugust 7, 2026

Medicare enrollment

From the CMS Doctors & Clinicians file — this clinician is enrolled in Medicare.

Medicare specialtyPULMONARY DISEASE
Also practisesINTERNAL MEDICINE
Medical schoolOTHER
Graduated 2017 (9 years in practice)
Accepts Medicare assignment Not indicated

Payments from drug and device companies, 2025

Drug and device makers are required by federal law (the Physician Payments Sunshine Act) to report what they pay or give to clinicians, and CMS publishes the reports as Open Payments. This is the 2025 program year. A report is a record of a payment, not an allegation of anything, and many are small items such as meals. Only general payments are listed here; research payments and ownership or investment interests are reported separately by CMS and are not shown.

Food and Beverage $125 1 payment · a meal or drink at a meeting or visit, not a fee

Each amount is the sum of what companies reported for that kind of payment in 2025, rounded to the dollar. Not all of it is income to the clinician: a meal is not a fee, a charitable contribution goes to a charity, and a royalty or an acquisition payment is not a salary.

Check a report, or dispute one, at the source in CMS’s own tool, Open Payments. Corrections go through CMS’s dispute process. This site removes a home address on request and asks for no proof, because that is privacy; it will not remove an accurate payment report on request, because that is a statutory public disclosure.

Other providers in Gainesville